We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
10 Year Est. Return
AUM
$730M
AUM Growth
+$40.7M
Cap. Flow
+$493K
Cap. Flow %
0.07%
Top 10 Hldgs %
28.63%
Holding
325
New
14
Increased
90
Reduced
109
Closed
10

Top Buys

Rank Stock Value
1
GGP
GGP Inc.
GGP
+$987K
2
ENB icon
Enbridge
ENB
+$766K
3
AMZN icon
Amazon
AMZN
+$641K
4
GILD icon
Gilead Sciences
GILD
+$524K
5
WDC icon
Western Digital
WDC
+$499K

Sector Composition

Rank Sector Weight
1 Healthcare 22.17%
2 Industrials 14.72%
3 Consumer Staples 10.5%
4 Financials 9.46%
5 Technology 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VO icon
76
Vanguard Mid-Cap ETF
VO
$107B
$2.29M 0.31%
65,680
-3,700
-5% -$127K
SLB icon
77
SLB Ltd
SLB
$74.2B
$2.27M 0.31%
29,007
-1,653
-5% -$135K
VB icon
78
Vanguard Small-Cap ETF
VB
$80.2B
$2.22M 0.3%
16,623
-900
-5% -$119K
JCI icon
79
Johnson Controls International
JCI
$85.6B
$2.18M 0.3%
51,847
+3,647
+8% +$154K
UAA icon
80
Under Armour
UAA
$3.04B
$2.1M 0.29%
106,356
-11,210
-10% -$261K
GMF icon
81
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$417M
$2.08M 0.29%
24,191
-905
-4% -$74.3K
AXP icon
82
American Express
AXP
$227B
$2.07M 0.28%
26,152
AAL icon
83
American Airlines Group
AAL
$10.2B
$2.06M 0.28%
48,736
-250
-0.5% -$11.3K
AGIO icon
84
Agios Pharmaceuticals
AGIO
$2.14B
$2.03M 0.28%
34,715
+1,300
+4% +$62.3K
ABBV icon
85
AbbVie
ABBV
$465B
$2.02M 0.28%
30,927
-1,950
-6% -$123K
EEM icon
86
iShares MSCI Emerging Markets ETF
EEM
$28B
$2.01M 0.28%
50,998
+2,233
+5% +$84.8K
CRM icon
87
Salesforce
CRM
$149B
$1.98M 0.27%
23,955
-200
-0.8% -$16K
LQD icon
88
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
$1.97M 0.27%
16,741
-6,167
-27% -$724K
MET icon
89
MetLife
MET
$62.7B
$1.97M 0.27%
41,892
+1,571
+4% +$74.9K
MDLZ icon
90
Mondelez International
MDLZ
$80.2B
$1.91M 0.26%
44,281
-7,595
-15% -$337K
AMT icon
91
American Tower
AMT
$79.9B
$1.9M 0.26%
15,630
-1,650
-10% -$182K
ICF icon
92
iShares Select U.S. REIT ETF
ICF
$2.13B
$1.88M 0.26%
37,714
+846
+2% +$42.3K
CI icon
93
Cigna
CI
$79.6B
$1.88M 0.26%
12,825
-100
-0.8% -$14.7K
OKS
94
DELISTED
Oneok Partners LP
OKS
$1.84M 0.25%
34,030
-100
-0.3% -$5K
MA icon
95
Mastercard
MA
$497B
$1.83M 0.25%
16,309
-247
-1% -$27.1K
MAC icon
96
Macerich
MAC
$7.52B
$1.77M 0.24%
27,550
VZ icon
97
Verizon
VZ
$201B
$1.71M 0.23%
34,971
-817
-2% -$41K
TWX
98
DELISTED
Time Warner Inc
TWX
$1.68M 0.23%
17,190
+159
+0.9% +$15.4K
KMI icon
99
Kinder Morgan
KMI
$70.3B
$1.67M 0.23%
76,759
-4,966
-6% -$109K
MON
100
DELISTED
Monsanto Co
MON
$1.65M 0.23%
14,574
+300
+2% +$33.2K

Similar funds

Gerald L. Ray & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Gerald L. Ray & Associates held 325 positions worth $730M, up 5.9% from $690M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gerald L. Ray & Associates's Q1 2017 filing shows 14 new, 90 increased, 109 reduced and 10 closed positions. Its largest new stake was GGP Inc.: 40,367 shares worth $936K. The largest sale was Lowe's Companies, an estimated $1.6M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q1 2017 buy was GGP Inc.: 40,367 shares worth $936K.
  • Gerald L. Ray & Associates added most to Amazon in Q1 2017, an estimated $641K increase.
  • Gerald L. Ray & Associates's biggest Q1 2017 reduction was Lowe's Companies, cutting an estimated $1.6M.
  • Gerald L. Ray & Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $757K.
  • Gerald L. Ray & Associates's ten largest holdings make up 29% of its $730M portfolio in Q1 2017.
  • Gerald L. Ray & Associates opened 14 new positions and closed 10 in Q1 2017.
  • Gerald L. Ray & Associates's portfolio value rose 5.9% quarter-over-quarter to $730M.

Based on Gerald L. Ray & Associates's 13F filing for Q1 2017, filed 3 May 2017.